MIRA INFORM REPORT

 

 

 

Report Date :

01.11.2008

 

IDENTIFICATION DETAILS

 

Name :

METRAN CO LTD

 

 

Registered Office :

2-12-18 Kawaguchi Kawaguchi City Saitama-Pref 332-0015

 

 

Country :

Japan

 

 

Financials (as on) :

30.04.2008

 

 

Date of Incorporation :

July 1984

 

 

Legal Form :

Limited Company (Kabushiki Kaisha)

 

 

Line of Business :

Manufactures of Medical Equipment and Devices, Especially Artificial Ventilators

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

YEN 16.5 Million

 

 

Status :

Small Company

 

 

Payment Behaviour :

Regular

 

 

Litigation :

--

 

 

name & address

 

METRAN CO LTD

REGD NAME:    KK Metran

MAIN OFFICE:  2-12-18 Kawaguchi Kawaguchi City Saitama-Pref 332-0015 JAPAN

                        Tel: 048-242-0333     Fax: 048-242-0550

 

URL:                 http://www.metran.co.jp/

E-Mail address: support_en@metran.co.jp

 

 

ACTIVITIES

 

Mfg of medical equipment & devices, especially artificial ventilators

 

 

BRANCHES

 

Nil

 

 

OVERSEAS

 

Vietnam (5) (--subsidiaries mfrs)

 

 

FACTORY(IES)

 

At the caption address

 

OFFICER(S)

TRAN NGOC PHUC

Mitsuko Nitta, dir

Shizuko Kato, dir

 

Yen Amount:    In million Yen, unless otherwise stated

 

 

SUMMARY

 

FINANCES        FAIR                 A/SALES          Yen 900 M

PAYMENTS      REGULAR         CAPITAL           Yen 87 M

TREND             SLOW              WORTH            Yen 135 M

STARTED         1984                 EMPLOYES      31

 


 

COMMENT

 

MFR OF MEDICAL INSTRUMENTS. 

FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY        BUSINESS ENGAGEMENTS.

 

MAX CREDIT LIMIT: YEN 16.5 MILLION, 30 DAYS NORMAL TERMS

 

 

HIGHLIGHTS

           

The subject company was established by Tran Ngoc Phuc (Japanese name: Kazufuku Nitta) in order to make most of his experience in the subject line of business.  Specializes in mfg medical instruments, especially artificial ventilators, anaesthesis devices, respiratory monitors and veterinary products.  Products are manufactured at the caption address as well as at Vietnam subsidiary factories and imported.  Domestic customers are University hospitals, general hospitals, veterinary hospitals, other, nationwide.  Goods are both imported and exported.  Has 7 overseas dealer distributors.

 

 

FINANCIAL INFORMATION

 

Financials are only partially disclosed.

 

The sales volume for Apr/2008 fiscal term amounted to Yen 900 million, a 13% down from Yen 1,030 million in the previous term.  The higher Yen against foreign currencies worked to decrease sales amount in Yen terms, although exports & imports went steady.  The net profit was posted at Yen 30 million, compared with Yen 1 million a year ago.  Reportedly some extraordinary incomes are involved.

 

For the current term ending Apr 2009 the net profit is projected at Yen 25million, on a 6% rise in turnover, to Yen 950 million.  Demand for artificial ventilators is expected to increase.

           

The financial situation is considered maintained FAIR and good for ORDINARY business engagements.       Max credit limit is estimated at Yen 16.5 million, on 30 days normal terms.

 

 

REGISTRATION

 

Date Registered:  Jul 1984

Legal Status:      Limited Company (Kabushiki Kaisha)

Authorized:         6,400 shares

Issued:               1,750 shares

Sum:                 Yen 87.5 million

Major shareholders (%): Tran Ngoc Phuc (51)

No. of shareholders: 7

           

Nothing detrimental is known as to the commercial morality of executives.


 

OPERATION

 

Activities: Manufactures, imports and exports artificial ventilators for infants & adults, anaesthesis devices, respiratory monitors, finger pulse oximeters, humidifiers/heaters, veterinary artificial ventilators for anesthesial use, other (--100%).

 

Overseas dealer distributors:

Medions (Korea); Metran Medical Co Ltd (Vietnam); Pulmocare Consultants (India), PT Murti Indah Sentosa (Indonesia); Shriro (Malaysia) Sdn Bhd (Malaysia); IDEM (Mexico); Biotran Inc (USA)

 

 

Clients

 

[Hospitals, medical instruments dealers] Iwaki Co Ltd, Koike Medical Corp, Univ of Tokyo Hospital, Kyoto Univ Hospital, Osaka Univ Hospital, National Center for Child Health & Development, Saitama Children’s Medical Center, other.

No. of accounts: 500

Domestic areas of activities: Nationwide

 

 

Suppliers

 

 [Mfrs, wholesalers] Sankyo Shoji, Oemu Kiki, other.

 

Payment record: Regular

 

Location: Business area in Kawaguchi City, Saitama-Pref.  Office premises at the caption address are owned and maintained satisfactorily.

 

 

Bank References

           

SMBC (Kawaguchi)

Sugamo Shinkin Bank (Nishi-Kawaguchi)

Relations: Satisfactory

 

 

FINANCES: (In Million Yen)

 

Terms Ending:

 

30/04/2009

30/04/2008

30/04/2007

30/04/2006

Annual Sales

 

950

900

1,030

800

Recur. Profit

 

 

 

 

 

Net Profit

 

25

30

1

-10

Total Assets

 

 

N/A

N/A

N/A

Net Worth

 

 

135

100

99

Capital, Paid-Up

 

 

87

87

87

Div.P.Share(¥)

 

 

0.00

0.00

0.00

<Analytical Data>

(%)

(%)

(%)

(%)

       S.Growth Rate

5.56

-12.62

28.75

3.90

     Current Ratio

 

 

..

..

..

       N.Worth Ratio

 

..

..

..

       N.Profit/Sales

2.63

3.33

0.10

-1.25

 

Notes: Financials are only partially disclosed.

Forecast (or estimated) figures for the 30/04/2009 fiscal term. 

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.49.25

UK Pound

1

Rs.80.36

Euro

1

Rs.62.84

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions